Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Effacy and Safety of Topiramate in Subjects With Restless Legs Syndrome (RLS)

NCT00200941 is registered in ClinicalTrials.gov with Neurocare as lead sponsor.

NCT NCT00200941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00200941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Effacy and Safety of Topiramate in Subjects With Restless Legs Syndrome (RLS)
Lead sponsor
Neurocare
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2001
Completion date
April 30, 2005
Enrollment
44
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

restless legs syndrome